top of page

BackTable / Urology / Podcast / Episode #227

Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors

with Dr. Nabil Adra and Dr. Richard Matulewicz

What does it take to deliver truly personalized, multidisciplinary care in testicular cancer? Get an inside look in this episode of BackTable Urology, where renowned testicular cancer experts Dr. Nabil Adra and Dr. Richard Matulewicz join host Dr. Aditya Bagrodia for a virtual tumor board session on the nuanced management of germ cell tumors. This episode was produced in collaboration with the Society of Urologic Oncology.

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors with Dr. Nabil Adra and Dr. Richard Matulewicz on the BackTable Urology Podcast)
Ep 227 Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors with Dr. Nabil Adra and Dr. Richard Matulewicz
00:00 / 01:04

BackTable, LLC (Producer). (2025, April 22). Ep. 227 – Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Nabil Adra discusses Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors on the BackTable 227 Podcast

Dr. Nabil Adra

Dr. Nabil Adra is a hematologist and Associate Professor of Clinical Medicine and Urology at Indiana University Health in Indianapolis, Indiana.

Dr. Richard Matulewicz discusses Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors on the BackTable 227 Podcast

Dr. Richard Matulewicz

Dr. Richard Matulewicz is a urologic oncologist and surgeon at Memorial Sloan Kettering Cancer Center in New York City.

Dr. Aditya Bagrodia discusses Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors on the BackTable 227 Podcast

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Synopsis

The expert panel uses specific patient cases to review their decision-making processes on the use of surgery, chemotherapy, and radiation. They highlight the importance of a multidisciplinary approach, particularly for advanced disease and challenging surgical scenarios. The episode reviews patient-specific factors, standard treatment protocols, post-treatment surveillance, and the latest research. This episode also highlights the benefits of personalized cancer care.

Timestamps

00:00 - Introduction
01:45 - Case Presentation: 23-Year-Old Male with Testicular Mass
02:14 - Initial Counseling and Management
04:03 - Orchiectomy and Post-Surgery
06:27 - Stage I Management
10:00 - Surveillance and Adjuvant Therapy
13:56 - Recurrence
23:13 - Case Study: 44-Year-Old with Non-Seminoma
28:14 - Case Study: 17-Year-Old with Developmental Delay and Cancer
29:42 - Chemotherapy Decisions
30:31 - Brain Imaging and Metastasis Predictions
33:54 - Chemotherapy Regimens
35:53 - Monitoring and Salvage Therapy
45:01 - Case Study: 21-Year-Old with Teratoma
55:21 - Concluding Thoughts

Resources

Society of Urologic Oncology:
https://suonet.org/home.aspx

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast)

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

bottom of page